Akoya BioSciences, Inc. (AKYA) Dividend History

Akoya Biosciences, Inc. is a life sciences company that specializes in spatial biology solutions, enabling researchers to visualize and analyze cellular interactions within tissue samples. Their platform combines advanced imaging and data analytics to support research in immunology, oncology, and other fields, facilitating a better understanding of tissue architecture and cellular behavior.

100 Campus Drive, Marlborough, MA, 01762
Phone: 855.896.8401
Website: https://www.akoyabio.com

Dividend History

Akoya BioSciences, Inc. currently does not pay dividends

Company News

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

The article discusses the growing cancer treatment market, with a focus on companies like Oncolytics Biotech, Akoya Biosciences, Quanterix, TScan Therapeutics, and Arcellx. It highlights new data and collaborations that signal a turning point for precision-driven cancer biotechs.

Benzinga

Featured Companies: ACLX ONCY QTRX TCRX
$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of AKYA, WTMA, PLYA, QTRX to Act Now

Monteverde & Associates PC, a class action law firm, is investigating several proposed mergers, including Akoya Biosciences' merger with Quanterix, Welsbach Technology Metals Acquisition's merger with Evolution Metals LLC, and Playa Hotels & Resorts' merger with Hyatt Hotels Corporation.

GlobeNewswire Inc.

Featured Companies: H PLYA QTRX
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of GB, YOTA, PORT, AKYA to Act

The M&A Class Action Firm is investigating the proposed mergers of Global Blue Group Holding, Yotta Acquisition Corporation, Southport Acquisition Corporation, and Akoya Biosciences with other companies. The firm encourages shareholders to act on these mergers.

Benzinga
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF

Monteverde & Associates PC is investigating the proposed mergers of OptiNose, Acelyrin, Akoya Biosciences, and Shyft Group. The firm is urging shareholders to take action regarding these mergers.

GlobeNewswire Inc.

Featured Companies: SHYF
Spatial Proteomics Market Report and Competitive Landscape 2025-2030, with 10X Genomics, Bruker, Fluidigm, Akoya Biosciences, PerkinElmer, Biotechne, S2 Genomics, Seven Bridges Genomics & More

The global spatial proteomics market is expected to reach $199.8 million by 2030, driven by the growing demand for precision medicine and personalized therapies, particularly in oncology. Key growth drivers include increasing investment in proteomics research and the rising prevalence of chronic diseases.

GlobeNewswire Inc.

Featured Companies: BRKR PKI TECH TXG

Dividend data last updated 06/07/2025 07:21:19 UTC